{"id":44734,"date":"2022-06-06T12:01:45","date_gmt":"2022-06-06T10:01:45","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-the-nic-cartridge-for-isolating-nuclei-from-sub-20-mg-tissue-samples\/"},"modified":"2022-06-06T12:01:45","modified_gmt":"2022-06-06T10:01:45","slug":"s2-genomics-announces-the-nic-cartridge-for-isolating-nuclei-from-sub-20-mg-tissue-samples","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-the-nic-cartridge-for-isolating-nuclei-from-sub-20-mg-tissue-samples\/","title":{"rendered":"S2 Genomics Announces the NIC+ Cartridge for Isolating Nuclei from Sub-20 mg Tissue Samples"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n<b>Poster Presented at AGBT 2022 General Meeting Demonstrates <\/b><b>the NIC+ Improves the Efficiency and Reliability of <\/b><b>Nuclei Isolations for Sub-20 mg Samples<\/b>\n<\/p>\n<p>LIVERMORE, Calif.&#8211;(BUSINESS WIRE)&#8211;<a href=\"https:\/\/twitter.com\/hashtag\/AGBT2022?src=hash\" target=\"_blank\" rel=\"noopener\">#AGBT2022<\/a>&#8211;S2 Genomics, a manufacturer of automated tissue sample preparation systems, announced today at the Advances in Genome Biology and Technology (AGBT) 2022 general meeting the launch of the NIC+ Small Sample Cartridge for nuclei isolations from solid tissue. When used with the Singulator 100 <sup>TM<\/sup> System, the NIC+ cartridges automate the processing of solid tissue samples into suspensions of single nuclei with high yields and from sub-20 mg samples for a wide range of single-cell biology and genomic analyses.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220606005233\/en\/834457\/5\/S2G-Primary-Gradient.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220606005233\/en\/834457\/21\/S2G-Primary-Gradient.jpg\"><\/a><\/p>\n<p>\nResearchers are often faced with the challenge of isolating nuclei from scarce, precious samples. Samples less than 20 mg are often too small in size for efficient and reliable processing by manual methods. To ensure that researchers can isolate nuclei from sub-20 mg samples with consistency, the NIC+ cartridge (P\/N 100-215-389) was developed for the Singulator 100 platform. A series of experiments were conducted to establish the performance of the NIC+ cartridges with respect to nuclei yield and quality.\n<\/p>\n<p>\n\u201cWe\u2019ve demonstrated that the NIC+ cartridge yields more, higher quality nuclei than the standard nuclei isolation cartridges,\u201d said Dr. Stevan Jovanovich, President and CEO of S2 Genomics.\n<\/p>\n<p>\nThe NIC+ Small Volume cartridges will begin shipping in July 2022.\n<\/p>\n<p>\n<b>About S2 Genomics, Inc.<\/b>\n<\/p>\n<p>\nS2 Genomics, founded in 2016, is a leading developer of laboratory automation solutions for processing solid tissues for life science applications. S2 Genomics\u2019 technology platforms integrate advanced fluidics, optics, and biochemistry to produce automated sample preparation solutions for the next generation sequencing (NGS) and cell biology markets, enabling discovery and innovation in life science research, healthcare, and agriculture. For more information, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fs2genomics.com&amp;esheet=52739318&amp;newsitemid=20220606005233&amp;lan=en-US&amp;anchor=https%3A%2F%2Fs2genomics.com&amp;index=1&amp;md5=8dc0959dd61757a29d5d993fd1d51a39\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/s2genomics.com<\/a>.\n<\/p>\n<p>\nFor Research Use Only. Not for use in diagnostic procedures.\n<\/p>\n<p>\nS2 Genomics, the S2 Genomics logo, and Singulator are trademarks of S2 Genomics, Inc.\n<\/p>\n<p>\nRead the full press release here: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fs2genomics.com%2Fs2-genomics-announces-the-nic-cartridge-for-isolating-nuclei-from-sub-20-mg-tissue-samples&amp;esheet=52739318&amp;newsitemid=20220606005233&amp;lan=en-US&amp;anchor=https%3A%2F%2Fs2genomics.com%2Fs2-genomics-announces-the-nic-cartridge-for-isolating-nuclei-from-sub-20-mg-tissue-samples&amp;index=2&amp;md5=af26bcfef202d70d2f450f7e53277d51\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/s2genomics.com\/s2-genomics-announces-the-nic-cartridge-for-isolating-nuclei-from-sub-20-mg-tissue-samples<\/a>\n<\/p>\n<p>\nNIC+ Product information can be found here: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fs2genomics.com%2Fsmall-sample-cartridge%2F&amp;esheet=52739318&amp;newsitemid=20220606005233&amp;lan=en-US&amp;anchor=https%3A%2F%2Fs2genomics.com%2Fsmall-sample-cartridge%2F&amp;index=3&amp;md5=a0acec48b428f13e9ab4ecc5b717b0ba\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/s2genomics.com\/small-sample-cartridge\/<\/a>\n<\/p>\n<p>\nFor the technical note visit: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fs2genomics.com%2Ftech-note-use-of-nic-with-the-singulator-100-for-sub-20mg-samples&amp;esheet=52739318&amp;newsitemid=20220606005233&amp;lan=en-US&amp;anchor=https%3A%2F%2Fs2genomics.com%2Ftech-note-use-of-nic-with-the-singulator-100-for-sub-20mg-samples&amp;index=4&amp;md5=e28375155aed65ee7fba3b0ea91d7a23\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/s2genomics.com\/tech-note-use-of-nic-with-the-singulator-100-for-sub-20mg-samples<\/a> To request a download of our AGBT 2022 posters or view the abstracts visit: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Finfo.s2genomics.com%2Fen-us%2Fagbt-2022-posters&amp;esheet=52739318&amp;newsitemid=20220606005233&amp;lan=en-US&amp;anchor=https%3A%2F%2Finfo.s2genomics.com%2Fen-us%2Fagbt-2022-posters&amp;index=5&amp;md5=06a5acef729979425ed452ccd9be45d7\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/info.s2genomics.com\/en-us\/agbt-2022-posters<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nStevan Jovanovich<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;i&#108;&#x74;&#111;&#x3a;s&#116;&#x65;v&#x61;&#x6e;&#106;&#x40;s&#50;&#x67;e&#x6e;&#x6f;&#109;&#x69;c&#115;&#x2e;&#99;&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">&#115;&#x74;&#101;&#x76;&#97;&#x6e;j&#x40;s&#x32;g&#101;&#x6e;&#111;&#x6d;&#105;&#x63;&#115;&#x2e;c&#x6f;m<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Poster Presented at AGBT 2022 General Meeting Demonstrates the NIC+ Improves the Efficiency and Reliability of Nuclei Isolations for Sub-20 mg Samples LIVERMORE, Calif.&#8211;(BUSINESS WIRE)&#8211;#AGBT2022&#8211;S2 Genomics, a manufacturer of automated tissue sample preparation systems, announced today at the Advances in Genome Biology and Technology (AGBT) 2022 general meeting the launch of the NIC+ Small Sample &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-the-nic-cartridge-for-isolating-nuclei-from-sub-20-mg-tissue-samples\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-44734","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>S2 Genomics Announces the NIC+ Cartridge for Isolating Nuclei from Sub-20 mg Tissue Samples - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-the-nic-cartridge-for-isolating-nuclei-from-sub-20-mg-tissue-samples\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"S2 Genomics Announces the NIC+ Cartridge for Isolating Nuclei from Sub-20 mg Tissue Samples - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Poster Presented at AGBT 2022 General Meeting Demonstrates the NIC+ Improves the Efficiency and Reliability of Nuclei Isolations for Sub-20 mg Samples LIVERMORE, Calif.&#8211;(BUSINESS WIRE)&#8211;#AGBT2022&#8211;S2 Genomics, a manufacturer of automated tissue sample preparation systems, announced today at the Advances in Genome Biology and Technology (AGBT) 2022 general meeting the launch of the NIC+ Small Sample ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-the-nic-cartridge-for-isolating-nuclei-from-sub-20-mg-tissue-samples\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-06T10:01:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220606005233\/en\/834457\/21\/S2G-Primary-Gradient.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/s2-genomics-announces-the-nic-cartridge-for-isolating-nuclei-from-sub-20-mg-tissue-samples\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/s2-genomics-announces-the-nic-cartridge-for-isolating-nuclei-from-sub-20-mg-tissue-samples\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"S2 Genomics Announces the NIC+ Cartridge for Isolating Nuclei from Sub-20 mg Tissue Samples\",\"datePublished\":\"2022-06-06T10:01:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/s2-genomics-announces-the-nic-cartridge-for-isolating-nuclei-from-sub-20-mg-tissue-samples\\\/\"},\"wordCount\":394,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/s2-genomics-announces-the-nic-cartridge-for-isolating-nuclei-from-sub-20-mg-tissue-samples\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220606005233\\\/en\\\/834457\\\/21\\\/S2G-Primary-Gradient.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/s2-genomics-announces-the-nic-cartridge-for-isolating-nuclei-from-sub-20-mg-tissue-samples\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/s2-genomics-announces-the-nic-cartridge-for-isolating-nuclei-from-sub-20-mg-tissue-samples\\\/\",\"name\":\"S2 Genomics Announces the NIC+ Cartridge for Isolating Nuclei from Sub-20 mg Tissue Samples - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/s2-genomics-announces-the-nic-cartridge-for-isolating-nuclei-from-sub-20-mg-tissue-samples\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/s2-genomics-announces-the-nic-cartridge-for-isolating-nuclei-from-sub-20-mg-tissue-samples\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220606005233\\\/en\\\/834457\\\/21\\\/S2G-Primary-Gradient.jpg\",\"datePublished\":\"2022-06-06T10:01:45+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/s2-genomics-announces-the-nic-cartridge-for-isolating-nuclei-from-sub-20-mg-tissue-samples\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/s2-genomics-announces-the-nic-cartridge-for-isolating-nuclei-from-sub-20-mg-tissue-samples\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/s2-genomics-announces-the-nic-cartridge-for-isolating-nuclei-from-sub-20-mg-tissue-samples\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220606005233\\\/en\\\/834457\\\/21\\\/S2G-Primary-Gradient.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220606005233\\\/en\\\/834457\\\/21\\\/S2G-Primary-Gradient.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/s2-genomics-announces-the-nic-cartridge-for-isolating-nuclei-from-sub-20-mg-tissue-samples\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"S2 Genomics Announces the NIC+ Cartridge for Isolating Nuclei from Sub-20 mg Tissue Samples\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"S2 Genomics Announces the NIC+ Cartridge for Isolating Nuclei from Sub-20 mg Tissue Samples - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-the-nic-cartridge-for-isolating-nuclei-from-sub-20-mg-tissue-samples\/","og_locale":"en_US","og_type":"article","og_title":"S2 Genomics Announces the NIC+ Cartridge for Isolating Nuclei from Sub-20 mg Tissue Samples - Pharma Trend","og_description":"Poster Presented at AGBT 2022 General Meeting Demonstrates the NIC+ Improves the Efficiency and Reliability of Nuclei Isolations for Sub-20 mg Samples LIVERMORE, Calif.&#8211;(BUSINESS WIRE)&#8211;#AGBT2022&#8211;S2 Genomics, a manufacturer of automated tissue sample preparation systems, announced today at the Advances in Genome Biology and Technology (AGBT) 2022 general meeting the launch of the NIC+ Small Sample ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-the-nic-cartridge-for-isolating-nuclei-from-sub-20-mg-tissue-samples\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-06T10:01:45+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220606005233\/en\/834457\/21\/S2G-Primary-Gradient.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-the-nic-cartridge-for-isolating-nuclei-from-sub-20-mg-tissue-samples\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-the-nic-cartridge-for-isolating-nuclei-from-sub-20-mg-tissue-samples\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"S2 Genomics Announces the NIC+ Cartridge for Isolating Nuclei from Sub-20 mg Tissue Samples","datePublished":"2022-06-06T10:01:45+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-the-nic-cartridge-for-isolating-nuclei-from-sub-20-mg-tissue-samples\/"},"wordCount":394,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-the-nic-cartridge-for-isolating-nuclei-from-sub-20-mg-tissue-samples\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220606005233\/en\/834457\/21\/S2G-Primary-Gradient.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-the-nic-cartridge-for-isolating-nuclei-from-sub-20-mg-tissue-samples\/","url":"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-the-nic-cartridge-for-isolating-nuclei-from-sub-20-mg-tissue-samples\/","name":"S2 Genomics Announces the NIC+ Cartridge for Isolating Nuclei from Sub-20 mg Tissue Samples - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-the-nic-cartridge-for-isolating-nuclei-from-sub-20-mg-tissue-samples\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-the-nic-cartridge-for-isolating-nuclei-from-sub-20-mg-tissue-samples\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220606005233\/en\/834457\/21\/S2G-Primary-Gradient.jpg","datePublished":"2022-06-06T10:01:45+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-the-nic-cartridge-for-isolating-nuclei-from-sub-20-mg-tissue-samples\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/s2-genomics-announces-the-nic-cartridge-for-isolating-nuclei-from-sub-20-mg-tissue-samples\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-the-nic-cartridge-for-isolating-nuclei-from-sub-20-mg-tissue-samples\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220606005233\/en\/834457\/21\/S2G-Primary-Gradient.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220606005233\/en\/834457\/21\/S2G-Primary-Gradient.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/s2-genomics-announces-the-nic-cartridge-for-isolating-nuclei-from-sub-20-mg-tissue-samples\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"S2 Genomics Announces the NIC+ Cartridge for Isolating Nuclei from Sub-20 mg Tissue Samples"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44734","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44734"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44734\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44734"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44734"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44734"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}